TriSalus Life Sciences (TLSI) Net Margin (2022 - 2026)
TriSalus Life Sciences (TLSI) posted quarterly Net Margin of 17.29% for Q1 2026, up 13824.0% year-over-year from N/an in Q1 2025, and up 123.42% quarter-over-quarter from 73.86% in Q4 2025.
TriSalus Life Sciences (TLSI) Net Margin (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Net Margin history runs 5 years deep, the most recent figure standing at 17.29% for Q1 2026.
- In Q1 2026, Net Margin rose 13824.0% year-over-year to 17.29%; the TTM figure through Mar 2026 stood at 130.32% (down 3600.0% YoY), while the FY2025 annual figure was 154.35%, down 4143.0% from the prior year.
- Net Margin for Q1 2026 stood at 17.29%, up from 73.86% in the prior quarter.
- The five-year high for Net Margin was 17.29% in Q1 2026, with the low at 786.45% in Q4 2022.
- The 5-year median for Net Margin is 131.84% (2024), against an average of 226.58%.
- The sharpest annual moves came in 2024 and 2025: Net Margin jumped 50510 bps in 2024, then plunged 31329 bps in 2025.
- TriSalus Life Sciences' Net Margin stood at 786.45% in 2022, then gained by 19 bps to 636.93% in 2023, then surged by 79 bps to 131.84% in 2024, then jumped by 44 bps to 73.86% in 2025, then soared by 123 bps to 17.29% in 2026.
- Business Quant data shows TLSI's Net Margin at 17.29% in Q1 2026, 73.86% in Q4 2025, and 356.86% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.12 Bn | 193.52 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 128.79 Bn | 125.32 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 119.30 Bn | 110.08 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 73.50 Bn | 72.96 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.86 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.62 Bn | 32.67 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.42 Bn | 23.10 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | 13.47% |
| 10 | TriSalus Life Sciences | 307.81 Mn | 261.52 Mn | 9.90 Mn | -80.54% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -80.54% |
| Mar 31, 2026 | 17.29% |
| Dec 31, 2025 | -73.86% |
| Sep 30, 2025 | -356.86% |
| Jun 30, 2025 | -80.28% |
| Mar 31, 2025 | -120.94% |
| Dec 31, 2024 | -131.84% |
| Sep 30, 2024 | -43.57% |
| Jun 30, 2024 | -69.70% |
| Mar 31, 2024 | -216.93% |
| Dec 31, 2023 | -636.93% |
| Sep 30, 2023 | -36.26% |
| Jun 30, 2023 | -346.83% |
| Mar 31, 2023 | -309.22% |
| Dec 31, 2022 | -786.45% |
| Sep 30, 2022 | -206.30% |